Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.42025
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.30 0.00 (0.00%)

89.87% Fall from 52W High

1.2M

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

15.5 / 100

Technically Neutral

41.3 / 100

No estimates available

Pliant Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

89.87% Fall from 52W High

SWOT Analysis

Pliant Therapeutics Inc Live Price Chart